Research Paper Volume 13, Issue 1 pp 181—193

The adhesion molecule ICAM-1 in diffuse large B-cell lymphoma post-rituximab era: relationship with prognostic importance and rituximab resistance

ICAM-1 expression in DLBCL patients. Representative immunohistochemical staining of ICAM-1 with negative (A) and positive (B) expression. (C) Overexpression of ICAM-1 in GCB and non-GCB subtypes.

Figure 1. ICAM-1 expression in DLBCL patients. Representative immunohistochemical staining of ICAM-1 with negative (A) and positive (B) expression. (C) Overexpression of ICAM-1 in GCB and non-GCB subtypes.